These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 9974121

  • 1. Effect of selegiline on dopamine concentration in the striatum of a primate.
    Kaseda S, Nomoto M, Iwata S.
    Brain Res; 1999 Jan 02; 815(1):44-50. PubMed ID: 9974121
    [Abstract] [Full Text] [Related]

  • 2. Effects of subchronic treatment with selegiline on L-DOPA-induced increase in extracellular dopamine level in rat striatum.
    Adachi K, Miwa H, Kusumoto H, Shimazu S, Kondo T.
    J Pharmacol Sci; 2006 Aug 02; 101(4):286-92. PubMed ID: 16891770
    [Abstract] [Full Text] [Related]

  • 3. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct 02; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 4. In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism.
    Brannan T, Prikhojan A, Martínez-Tica J, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1995 Oct 02; 10(2-3):79-89. PubMed ID: 9620056
    [Abstract] [Full Text] [Related]

  • 5. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
    Finberg JP, Wang J, Goldstein DS, Kopin IJ, Bankiewicz KS.
    J Neurochem; 1995 Sep 02; 65(3):1213-20. PubMed ID: 7643100
    [Abstract] [Full Text] [Related]

  • 6. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T, Lamensdorf I, Finberg JP.
    Br J Pharmacol; 2000 Aug 02; 130(8):1992-8. PubMed ID: 10952692
    [Abstract] [Full Text] [Related]

  • 7. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW.
    J Neurochem; 1990 Sep 02; 55(3):981-8. PubMed ID: 2117053
    [Abstract] [Full Text] [Related]

  • 8. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR, Abercrombie ED.
    J Neurochem; 1994 Jul 02; 63(1):108-17. PubMed ID: 8207420
    [Abstract] [Full Text] [Related]

  • 9. Modulation of dihydroxyphenylacetaldehyde extracellular levels in vivo in the rat striatum after different kinds of pharmacological treatment.
    Fornai F, Giorgi FS, Bassi L, Ferrucci M, Alessandrì MG, Corsini GU.
    Brain Res; 2000 Apr 07; 861(1):126-34. PubMed ID: 10751572
    [Abstract] [Full Text] [Related]

  • 10. Possible synergies between isatin, an endogenous MAO inhibitor, and antiparkinsonian agents on the dopamine release from striatum of freely moving rats.
    Faro LRF, Justo LA, Alfonso M, Durán R.
    Neuropharmacology; 2020 Jul 07; 171():108083. PubMed ID: 32304702
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study.
    Colzi A, d'Agostini F, Kettler R, Borroni E, Da Prada M.
    J Neural Transm Suppl; 1990 Jul 07; 32():79-84. PubMed ID: 2089114
    [Abstract] [Full Text] [Related]

  • 13. Oxygen inhalation enhances striatal dopamine metabolism and monoamineoxidase enzyme inhibition prevents it: a microdialysis study.
    Adachi YU, Watanabe K, Higuchi H, Satoh T, Vizi ES.
    Eur J Pharmacol; 2001 Jun 22; 422(1-3):61-8. PubMed ID: 11430914
    [Abstract] [Full Text] [Related]

  • 14. Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.
    Lamensdorf I, Porat S, Simantov R, Finberg JP.
    Br J Pharmacol; 1999 Feb 22; 126(4):997-1002. PubMed ID: 10193780
    [Abstract] [Full Text] [Related]

  • 15. Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.
    Yabe H, Choudhury ME, Kubo M, Nishikawa N, Nagai M, Nomoto M.
    J Pharmacol Sci; 2009 May 22; 110(1):64-8. PubMed ID: 19403994
    [Abstract] [Full Text] [Related]

  • 16. Modification of dopamine release by selective inhibitors of MAO-B.
    Finberg JP, Lamensdorf I, Armoni T.
    Neurobiology (Bp); 2000 May 22; 8(2):137-42. PubMed ID: 11061211
    [Abstract] [Full Text] [Related]

  • 17. The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.
    Gołembiowska K, Dziubina A.
    Neurotox Res; 2012 Aug 22; 22(2):150-7. PubMed ID: 22407500
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
    Sivam SP.
    Neuropeptides; 1993 Jul 22; 25(1):35-45. PubMed ID: 7692341
    [Abstract] [Full Text] [Related]

  • 20. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S, Mukai T, Kurosaki K, Kuriiwa F, Endo T.
    Arch Toxicol; 2002 Oct 22; 76(10):596-605. PubMed ID: 12373456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.